Compare Stocks

Date Range: 

 Enzo BiochemProgenityExagenCentogeneOpGen
SymbolNYSE:ENZNASDAQ:PROGNASDAQ:XGNNASDAQ:CNTGNASDAQ:OPGN
Price Information
Current Price$2.90$3.09$15.50$9.75$2.42
52 Week RangeN/ABuyBuyBuyBuy
MarketRank™
Overall Score0.71.81.71.21.3
Analysis Score0.03.33.53.53.5
Community Score2.53.33.32.62.5
Dividend Score0.00.00.00.00.0
Ownership Score0.81.70.80.00.0
Earnings & Valuation Score0.00.60.60.00.6
Analyst Ratings
Consensus RecommendationN/ABuyBuyBuyBuy
Consensus Price TargetN/A$8.60$24.40$18.67$5.50
% Upside from Price TargetN/A178.32% upside57.42% upside91.45% upside127.27% upside
Trade Information
Market Cap$139.86 million$188.87 million$196.39 million$193.65 million$92.60 million
Beta0.89N/AN/A-2.25-0.44
Average Volume1,019,799498,15562,96958,1058,785,698
Sales & Book Value
Annual Revenue$76.02 millionN/A$40.39 million$54.64 million$3.50 million
Price / Sales1.84N/A4.863.5426.46
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.22 per shareN/A$4.43 per share$3.32 per share$0.77 per share
Price / Book2.38N/A3.502.943.14
Profitability
Net Income$-28,520,000.00N/A$-12,040,000.00$-23,360,000.00$-12,450,000.00
EPSN/AN/A($8.46)($1.46)($6.90)
Trailing P/E RatioN/A0.00N/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-24.36%N/A-39.49%N/A-586.99%
Return on Equity (ROE)-27.05%N/A-29.10%N/A-154.05%
Return on Assets (ROA)-14.76%N/A-17.88%N/A-68.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.08%N/A0.55%0.01%1.10%
Current Ratio2.09%1.07%12.77%1.92%1.74%
Quick Ratio1.85%0.95%12.77%1.71%1.39%
Ownership Information
Institutional Ownership Percentage60.38%17.08%29.21%15.80%2.29%
Insider Ownership Percentage9.40%80.60%48.90%N/A0.36%
Miscellaneous
Employees40863518144038
Shares Outstanding48.23 million60.34 million12.67 million19.86 million38.27 million
Next Earnings Date6/14/2021 (Estimated)6/17/2021 (Estimated)5/11/2021 (Confirmed)6/21/2021 (Estimated)5/6/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
OpGen : Corporate Presentation (PDF) - Marketscreener.comOpGen : Corporate Presentation (PDF) - Marketscreener.com
marketscreener.com - May 2 at 6:33 PM
Global Outbounding Service Market 2020-2025 (Impact of Covid-19) | OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, OpenMoves, etc. - Clark County BlogGlobal Outbounding Service Market 2020-2025 (Impact of Covid-19) | OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, OpenMoves, etc. - Clark County Blog
clarkcountyblog.com - May 1 at 9:18 AM
Global Outbound Marketing Service Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, etc. - Clark County BlogGlobal Outbound Marketing Service Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, Revenue River, Disruptive Advertising, CIENCE, Square 2 Marketing, etc. - Clark County Blog
clarkcountyblog.com - April 30 at 9:00 AM
OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time - GlobeNewswireOpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time - GlobeNewswire
globenewswire.com - April 29 at 8:33 AM
OpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern TimeOpGen to Provide Business Update and Financial Results for the First Quarter 2021 on May 13th at 8:30 a.m. Eastern Time
finance.yahoo.com - April 29 at 8:33 AM
OpGen Inc (OPGN) has gained 5.22% Tuesday In Premarket Trading - InvestorsObserverOpGen Inc (OPGN) has gained 5.22% Tuesday In Premarket Trading - InvestorsObserver
investorsobserver.com - April 27 at 5:34 PM
Global Outbound Marketing Services Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, CIENCE, WebiMax, BlueFocus, RightHello, etc. - Clark County BlogGlobal Outbound Marketing Services Market 2021 Analysis By Growth Trends And Forecast 2028: OpGen Media, CIENCE, WebiMax, BlueFocus, RightHello, etc. - Clark County Blog
clarkcountyblog.com - April 27 at 12:34 PM
Global Marketing Automation Consulting Services Market 2021 Analysis By Growth Trends And Forecast 2028: LeadMD, Perkuto, OpGen Media, Couch & Associates, Measured Results Marketing, etc. - Clark County BlogGlobal Marketing Automation Consulting Services Market 2021 Analysis By Growth Trends And Forecast 2028: LeadMD, Perkuto, OpGen Media, Couch & Associates, Measured Results Marketing, etc. - Clark County Blog
clarkcountyblog.com - April 27 at 7:33 AM
OpGen (OPGN) Stock Is Up Today in Pre-Hours Trade, Why? - Market GlobalistOpGen (OPGN) Stock Is Up Today in Pre-Hours Trade, Why? - Market Globalist
marketglobalist.com - April 27 at 7:33 AM
Digital Marketing Service Market Outlook: Big Expectations to Watch For OpenMoves, WebiMax, OpGen Media - Clark County BlogDigital Marketing Service Market Outlook: Big Expectations to Watch For OpenMoves, WebiMax, OpGen Media - Clark County Blog
clarkcountyblog.com - April 26 at 5:18 AM
Outbound Market Impressive Gains including key players OpGen Media, CIENCE, WebiMax, BlueFocus – Clark County Blog - Clark County BlogOutbound Market Impressive Gains including key players OpGen Media, CIENCE, WebiMax, BlueFocus – Clark County Blog - Clark County Blog
clarkcountyblog.com - April 21 at 7:55 AM
OpGen, Inc. - Consensus Indicates Potential 184.1% Upside - DirectorsTalk InterviewsOpGen, Inc. - Consensus Indicates Potential 184.1% Upside - DirectorsTalk Interviews
directorstalkinterviews.com - April 19 at 6:32 PM
OpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections - BioSpaceOpGen Extends and Expands Partnership with New York State Department of Health to Detect Antimicrobial-Resistant Infections - BioSpace
biospace.com - April 19 at 8:31 AM
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - Yahoo FinanceOpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - Yahoo Finance
finance.yahoo.com - April 14 at 6:13 AM
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in ...OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in ...
apnews.com - April 13 at 2:56 PM
Outbound Marketing Service Market May See a Big Move | OpGen Media, Revenue River, Disruptive Advertising – FLA News - FLA NewsOutbound Marketing Service Market May See a Big Move | OpGen Media, Revenue River, Disruptive Advertising – FLA News - FLA News
flanewsonline.com - April 12 at 6:25 PM
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - BioSpaceOpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients - BioSpace
biospace.com - April 12 at 8:24 AM
OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 PatientsOpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-infections in COVID-19 Patients
finance.yahoo.com - April 12 at 8:24 AM
OpGen Inc (OPGN) Down 3.68% in Premarket Trading - InvestorsObserverOpGen Inc (OPGN) Down 3.68% in Premarket Trading - InvestorsObserver
investorsobserver.com - April 9 at 12:06 PM
Should Diagnostics & Research Stock OpGen Inc (OPGN) Be in Your Portfolio Tuesday? - InvestorsObserverShould Diagnostics & Research Stock OpGen Inc (OPGN) Be in Your Portfolio Tuesday? - InvestorsObserver
investorsobserver.com - March 31 at 12:20 AM
OPGEN : Managements Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) - marketscreener.comOPGEN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K) - marketscreener.com
marketscreener.com - March 30 at 9:19 AM
Form 10-K OPGEN INC For: Dec 31 - StreetInsider.comForm 10-K OPGEN INC For: Dec 31 - StreetInsider.com
streetinsider.com - March 30 at 9:19 AM
OpGen, Inc. (NASDAQ:OPGN): Why Investors Shouldn’t Ditch OPGN stock in 2021OpGen, Inc. (NASDAQ:OPGN): Why Investors Shouldn’t Ditch OPGN stock in 2021
marketingsentinel.com - March 29 at 6:08 PM
Global Email Market Estimation 2021-2026 Analysis by Key Players like OpGen Media, Cience, RightHello, WebiMax, LeadMD, InboundLabs, etc. | Affluence - The Market EagleGlobal Email Market Estimation 2021-2026 Analysis by Key Players like OpGen Media, Cience, RightHello, WebiMax, LeadMD, InboundLabs, etc. | Affluence - The Market Eagle
themarketeagle.com - March 29 at 1:07 PM
CBS Streaming on Paramount+ - Yahoo EntertainmentCBS Streaming on Paramount+ - Yahoo Entertainment
yahoo.com - March 27 at 6:51 PM
DateCompanyBrokerageAction
3/21/2021ProgenityRobert W. BairdReiterated Rating
2/8/2021ProgenityWells Fargo & CompanyDowngrade
1/14/2021ProgenityPiper SandlerLower Price Target
11/10/2020ProgenityRaymond JamesLower Price Target
10/23/2020ProgenityBTIG ResearchInitiated Coverage
4/21/2021ExagenCanaccord GenuityInitiated Coverage
3/17/2021ExagenCowenBoost Price Target
3/8/2021ExagenKeyCorpBoost Price Target
11/11/2020ExagenWilliam BlairReiterated Rating
6/1/2020ExagenCantor FitzgeraldInitiated Coverage
12/16/2020CentogeneSVB LeerinkReiterated Rating
11/5/2020CentogeneCredit Suisse GroupInitiated Coverage
10/7/2020CentogeneKempen & CoInitiated Coverage
12/2/2019CentogeneEvercore ISIInitiated Coverage
3/15/2021OpGenHC WainwrightReiterated Rating
3/8/2021OpGenAlliance Global PartnersBoost Price Target
9/9/2019OpGenAegisSet Price Target
(Data available from 5/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.